| Literature DB >> 20177449 |
H Puzanowska-Tarasiewicz1, W Misiuk, K Mielech-Łukasiewicz, L Kuźmicka.
Abstract
Psychotropic drugs are an important family of compounds from a medical point of view. Their application in therapy requires methods for the determination in pharmaceutical dosage forms and body fluids. Several methods for their analysis have been reported in the literature. Among the methods, spectrophotometric and electrochemical are very useful for the determination of the drugs. Some of the spectrophotometric methods are based on the formation of the binary and ternary compounds with complexes of metals. The formed compounds are sparingly soluble in water, but quantitatively extracted from aqueous phase into organic solvents and the extracts are intensely colored and stable for a few days. These complexes have been employed in pharmaceutical analysis. The electrochemical procedures are very useful in determination of the psychotropic substances in pharmaceutical preparations.Entities:
Keywords: Psychotropic drugs; analysis; spectrophotometric and electrochemical methods
Year: 2009 PMID: 20177449 PMCID: PMC2810060 DOI: 10.4103/0250-474X.51942
Source DB: PubMed Journal: Indian J Pharm Sci ISSN: 0250-474X Impact factor: 0.975
Fig. 1Formulae of antipsychotic drugs
Formulae of dibenzoazepines (I), thioxanthenes (II), azaphenothiazines (III) phenothiazines (IV), olanzapine (V), trazodone (VI), sertraline (VII), paroxetine (VIII), fluoxetine (IX), fluvoxamine (X)
DETERMINATION OF PSYCHOTROPIC DRUGS IN BINARY SYSTEMS
| Psychotropic drugs | Organic reagents | Organic solvent | λ [nm] | ε [l·−mol−1cm−1] | Range of determination [ppm] | Ref. |
|---|---|---|---|---|---|---|
| Perphenazine | Dipicrylamine | chloroform | 420 | 1.09·104 | 8 - 60 | 21 |
| Chlorpromazine | chloroform | 420 | 3.22·104 | 0.7 - 7 | 22 | |
| Thioproperazine | 435 | 1.51·104 | 1.6-16 | |||
| Chlorpromazine | Alizarin S | chloroform | 420 | 8.00·103 | 7 - 70 | 23 |
| Promethazine | chloroform | 420 | 8.50·103 | 7 - 70 | 24 | |
| Chlorpromazine | Brilliant blue | chloroform | 620 | 2.21·104 | 1 - 10 | 25 |
| Fluphenazine | 1.02·104 | 2 - 10 | ||||
| Thioridazine | 2.78·104 | 1 - 10 | ||||
| Levomepromazine | Bromophenol blue | chloroform | 409 | - | 5 - 25 | 26 |
| Fluoxetine | Chrome | chloroform | 500 | 1.02·104 | 5-50 | 12 |
| Fluvoxamine | Azurol S | chloroform-butanol (3:1) | 502 | 9.05·103 | 7-100 | |
| Chlorpromazine | chloroform | 510 | 1.48·104 | 2 - 20 | 27 | |
| Promethazine | 2.04·104 | 1 - 12 | ||||
| Thioproperazine | 460 | 1.57·104 | 2 - 28 | 28 | ||
| Trifluopromazine | 2.12·104 | 1 - 12 | ||||
| Promethazine | Methyl orange | chloroform | - | - | 20-100 | 29 |
| Imipramine | Eriochrome Cyanine R | butanol | 520 | 4.80·103 | 10 - 80 | 30 |
| Chlorpromazine | Pyrocatechol | chloroform - | 445 | 1.04·104 | 3.5 - 35 | 31 |
| Chlorprothixene | violet | butanol (5:1) | ||||
| chloroform - butanol (5:1) | 445 | 1.40·104 | 3.5 - 32 | 32 | ||
| Chlorpromazine | Flavianic acid | benzene | 390 | 9.60·103 | 7- 70 | 33 |
| Thioridazine | 385 | - | 5 - 20 | 34 | ||
| Promazine | Picramic acid | chloroform | 500 | 2.10·103 | 8 - 80 | 35 |
| Thioproperazine | - | 16 - 160 | 36 | |||
| Thioridazine | Picric acid | benzene | 405 | - | 20 - 70 | 34 |
| Thioproperazine | 406 | 7.30·103 | 10 - 80 | 33 | ||
| Trifluoperazine | 406 | 6.70·103 | 10 - 100 | 37 | ||
| Perphenazine | 407 | 7.60·103 | 4-80 | 21 | ||
| Promazine | 405 | - | 10-60 | 38 | ||
| Methopromazine | ||||||
| Promethazine | Orange II | dichloro-methane | 485 | - | 5 - 20 | 25 |
| Fluphenazine | 1.02·104 | 3 - 25 | ||||
| Prochlorpromazine | chloroform | 495 | 5.40·104 | 30-130 | ||
| Trifluoperazine | 1.14·104 | 3 - 25 | 39 | |||
| Nortriptyline | chloroform | 490 | - | - | ||
| Chlorpromazine | Bromocresol green | chloroform | 420 | 2.63·104 | 2 - 8 | 40 |
| Trifluorpromazine | 2.02·104 | 2 -10 | ||||
| Thioproperazine | 2.65·104 | 2 -12 | ||||
| Thioridazine | 2.13·104 | 2 -18 | ||||
| Chlorpromazine | Titanium yellow | ethyl acetate | 405 | - | 10 - 60 | 41 |
| Fluoxetine | Eriochrome | butanol | 520 | 1.7·104 | 2-30 | 13 |
| Fluvoxamine | cyanine R | 518 | 6.5·103 | 2-40 | ||
| Trazodone | Bromophenol blue | chloroform | 414 | - | 3.75-14 | 11 |
Line denotes for lack reference
Scheme 1Possible structure of promazine-flavianic acid compound
Scheme 2The reaction of diethazine hydrochloride with [PdI4]2− The reaction of the protonated amine nitrogen of diethazine hydrochloride with the anionic complex of [PdI4]2−
DETRMINATION OF PSYCHOTROPIC DRUGS IN TERNARY SYSTEMS
| Psychotropic substance | System | Organic solvent | λ [nm] | ε [l·mol−1cm−1] | Range of determination [ppm] | Ref. |
|---|---|---|---|---|---|---|
| Levomepromazine (LPZ) | LPZ-[Cr(NH3)2(SCN)4] | acetone | 525 | 9.12·104 | 53 - 427 | 45 |
| Chlorpromazine (CPZ) | CPZ-[Cr(NH3)2(SCN)4] | acetone | 520 | 9.12·104 | 156 - 689 | 50 |
| Chlorpromazine (CPZ) | Fe(III)-SCN--CPZ | chloroform | 490 | - | 120 - 300 | 51 |
| Levomepromazine (LPZ) | Fe(III)-SCN--LPZ | 140 - 400 | ||||
| Promethazine (PMT) | Fe(III)-SCN--PMT | 160 - 550 | ||||
| Chlorpromazine (CPZ) | Co(II)-SCN--CPZ | ether | 620 | - | 100 - 600 | 52 |
| Chloracizine (CRZ) | Co(II)-SCN--CRZ | 100 - 900 | ||||
| Chlorpromazine (CPZ) | Ge(IV)-PCV-CPZ | cyclohexa-none | 580 | 6.8 ·103 | 7 - 70 | 53 |
| Chlorpromazine (CPZ) | Sn(IV)-PCV-CPZ | butanol | 580 | - | 2 - 20 | 31 |
| Desipramine (DE) | Ti(IV)- SCN-- DE | chloroform | 355 | 5.85 ·104 | 5 - 200 | 54 |
| Thioridazine (TR) | Ti(IV) - SCN-- TR | chloroform - | 417 | - | 20 - 160 | |
| Perazine (PZ) | Ti(IV) - SCN--PZ | butanol (4:1) | 360 | 8.96·103 | 20 - 170 | 55 |
| Amitriptyline (AM) | Ti(IV) - SCN--AM | 3 - 60 | ||||
| Promazine (PM) | Nb(V)-SCN--PM | trichloro-ethylene | 400 | - | 20 - 200 | 56 |
| Imipramine (IM) | Nb(V)- SCN-- IM | butanol-chloroform (1:9) | 350 | 6.67·104 | 0.8 - 8 | 43 |
| Doxepin (DX) | Ti(IV)- SCN-- DX | butanol-chloroform (2:3) | 400 | 7.12· 103 | 5 - 50 | 44 |
| Chlorprothixene (CX) | Nb(V)- SCN-- CX | butanol | 362 | 8·103 | 9 - 50 | 46 |
Line denotes for lack reference
Scheme 3Mechanism of ion pair complex trazodone-bromophenol blue system
Fig. 2Mechanism of electroreduction of trazodone
VOLTAMMETRIC ANALYSIS OF PSYCHOTROPIC DRUGS
| Psychotropic drug | Medium | Method | Working electrode | Range of determination [mol/l] | LOD [mol/l] | Practical application | Ref. | ||
|---|---|---|---|---|---|---|---|---|---|
| Chlorpromazine, | Britton's buffer, pH=2-7 | DPP | Hg | 6·10−6 - 1·10−4 | 3·10−7 | Drug | 58 | ||
| Promazine, | 5·10−6 - 8·10−5 | 3·10−7 | preparations | ||||||
| Promethazine | 8·10−6 - 1·10−4 | 4·10−7 | Urine | ||||||
| Chlorpromazine | 0.2 M H2SO4 | LSV | Ru | 2·10−4 - 8·10−4 | - | Drugs preparations | 72 | ||
| Thioridazine | 0.2 M H2SO4 | CV | Pt, | 5·10−5 - 1·10−3 | - | Drugs preparations | 73 | ||
| Ru, | 6·10−4 - 1·10−2 | ||||||||
| GC | 1·10−4 - 1·10−3 | ||||||||
| Fluphenazine | 0.5 M H2SO4, | CV | Pt, | 4·10−4 - 1·10−2 | - | Drugs preparations | 74 | ||
| Phosphate buffer, pH=6.2 | 2·10−4 - 4·10−3 | ||||||||
| 0.5 M H2SO4 | GC | 2·10−5 - 8·10−4 | |||||||
| Promazine, | 0.1 M HCl | LSV | CPE, | 2.5·10−5- 5·10−3 | - | Drugs preparations | 75 | ||
| Promethazine, | SCPE | 2.5·10−5- 5·10−3 | |||||||
| Levomepromazine | GC | 6.2·10−5-1.2·10−3 | |||||||
| Chlorpromazine, | 0.1 M NaClO4 | DPV | Pt | 7·10−7 -1.4·10−5 | 4·10−7 | Drugs preparations | 76 | ||
| Thioridazine | in acetonitrile | ||||||||
| Chlorpromazine, | Britton's buffer, pH=7.0 | AdSV | Hg | 2·10−8 -5·10−6 | 4.2·10−9 | Drugs preparations | 62 | ||
| (in the presence of Triton X-100) | Urine | ||||||||
| Ethopropazine | 0.05 M Phthalate buffer, pH=3.5 (in the presence of SDS) | CV | Au | 4·10−7 - 4·10−6 | - | - | 77 | ||
| Promethiazine, Diethazine, Trifluoperazine, Fluphenazine | Phosphate buffer, pH=7 | DPV | WIGE | 5·10−7 - 1·10−4 | 5·10−8 | Urine, plasma | 63 | ||
| Chlorpromazine | Phosphate buffer, pH=7 | DPV | WIGE | 4.8·10−8 - 2.4·10−4 | 5·10−9 | Urine | 78 | ||
| Chlorpromazine, | 0.1 M Phosphate | AdSV | CPE | 8.3·10−8 - 2·10−6 | 1·10−9 | Urine, | 79, | ||
| Perphenazine, Promazine | buffer, pH=7.4 | DPV | blood samples | 80 | |||||
| Chlorpromazine | 0.1 M Phosphate | AdSV | CPE | 1.5·10−6 - 9·10−6 | 1·10−7 | Urine | 81 | ||
| buffer, pH=7.4 | DPV | ||||||||
| Chlorpromazine, | Britton's buffer, pH=9 | AdSV | GC | 1.5·10−7 - 3.4·10−6 | 1.3·10−7 | Blood | 82 | ||
| Promethiazine | DPV | 3·10−7 - 3·10−6 | 1.2·10−7 | samples | |||||
| Phenothiazine, | Acetate buffer, | CV | MCPE | 2·10−8 - 3·10−7 | 1.2·10−8 | Drugs' | 83 | ||
| Chlorpromazine, | pH=5.0 | 7·10−9 | preparations | ||||||
| promethiazine | 5·10−9 | ||||||||
| Thioridazine, | Acetate buffer, | DPV | MCPE | 1·10−7 - 1·10−6 | 4.5·10−8 | Drugs' | 84 | ||
| Prochlorperazine, Chlorpromazine | pH=5 | 1.2·10−8 | preparations | ||||||
| Chlorpromazine, | Phosphate | DPV | MCPE | 1.96·10−7 - | 1·10−7 | Model | 64 | ||
| Thioridazine, | buffer, pH=7.4 | 2.75·10−6 | 7·10−8 | serum | |||||
| Prochlorperazine, | 4·10−8 | ||||||||
| Levomepromazine | 8·10−8 | ||||||||
| Thioridazine | Phosphate | AdSV | MCPE | 1·10−8 - 1·10−7 | 7·10−9 | Drugs' | 65 | ||
| buffer, pH=6.6 | CV, DPV | preparations | |||||||
| Fluphenazine | 0.05 M HCOOH- | CV | MAu | 5·10−8 - 1.5·10−5 | 1·10−8 | Drugs' | 85 | ||
| HCOONa buffer, pH=3.5 | preparations | ||||||||
| Perphenazine | 0.05 M borate | CV | MAu | 6·10−9 - 5·10−7 | Drugs' | 86 | |||
| buffer, pH=10.0 | 5·10−7 - 5·10−6 | - | preparations | ||||||
| Chlorpromazine | 0.05 M Phosphate | CV | MAu | 6·10−6 - 5·10−5 | - | Biological | 61 | ||
| buffer, pH=9 | fluids | ||||||||
| Promazine, | Acetate buffer, pH=4.7 | CV, | CPE, | 2·10−7 - 3·10−5 | down to 1·10−8 | Drugs' | 87 | ||
| Promethiazine, Trifluoperazine, Chlorpromazine, Thioridazine | A | SCPE | preparations | ||||||
| Prothipendyl | Britton's buffer, | DPP | Hg | - | - | Blood, plasma, | 59 | ||
| pH=3.5 | urine | ||||||||
| Imipramine | 0.1 M H2SO4, | CV | MCPE | 6·10−5 - 8·10−4 | - | Drugs' | 60 | ||
| Phosphate buffer, pH=7.4 | preparations | ||||||||
| Imipramine, | Phosphate buffer, | AdSV | MCPE | 1·10−7 - 1·10−6 | 2·10−8 | Drugs' | 65 | ||
| Trimipramine | pH=6.6 | CV, DPV | preparations | ||||||
| Imipramine, | Phosphate buffer, | DPV | MCPE | 1.96·10−7 - 2.4·10−6 | 1·10−7 | Plasma | 64 | ||
| Trimipramine, | pH=7.4 | 1.1·10−7 | |||||||
| Clomipramine | 0.5·10−7 | ||||||||
| Imipramine | Phosphate buffer, | LSV | MCPE | 1·10−7 - 8·10−6 | - | Drugs' | 88 | ||
| pH=9 | preparations, urine | ||||||||
| Imipramine, | Acetate buffer, | DPV | MCPE | 1·10−7 - 1·10−6 | 8.5 ·10−8 | Drugs' | 84 | ||
| Clomipramine, | pH=5 | 9.2 ·10−8 | preparations | ||||||
| Trimipramine | 9.0 ·10−8 | ||||||||
| Imipramine, | Phosphate buffer, | CV, | CPE, | 2·10−7 - 6·10−7 | 1.5·10−8 | Urine | 67 | ||
| Desipramine, | pH=9 | DPV | GC | 2·10−7 - 6·10−7 | 1.7·10−8 | ||||
| Trimipramine | 2·10−7 - 1.6·10−6 | 1.4·10−8 | |||||||
| Clomipramine | Britton's buffer, phosphate buffer | SWP | Hg | - | - | Drugs' preparations | 89 | ||
| Imipramine, | Phosphate buffer, | CV | GC, | - | - | Plasma | 6 | ||
| Clomipramine, Dezipramine | pH=6.9 | BDD | |||||||
| Imipramine, | 0.1 H2SO4 | LSV, | Pt, | - | - | - | 57 | ||
| Clomipramine, Dezipramine, Trimipramine | CV | Au | |||||||
| Zuclopenthixol | 0.1 M H2SO4, | CV, | GC | 8·10−7 - 2·10−4 | 2.2·10−7 | Drugs' preparations | 68 | ||
| Britton's buffer, pH=2.0 - 11.5, phosphate buffer, pH=5.2 - 8.3 | LSV, DPV | ||||||||
| Chlorprothixene | Britton's buffer, pH=8.2 | CV, DPV | GC | 0.1 - 1 μg/ml time of condition =30s 0.01 - 1 μg/ml time of condition = 120 s | - | Urine | 69 | ||
| Chlorprothixene, Thiothixene | 0.1 M HCl, Britton's buffer, pH=10.13 | dc-P | Hg | 2.7·10−5 - 1·10−4 | - | Drugs' preparations | 70 |
AdSV=adsorptive stripping voltammetry, CV= cyclic voltammetry, DPV= differential pulse voltammetry, LSV= linear sweep voltammetry, SWP = square wave polarography, dc-P=direct current polarography, ac-P=alternating current polarography, DPP=differential pulse polarography, A=amperometry, CPE= carbon paste electrode, SCPE= solid carbon paste electrode, GC=glassy carbon electrode, MCPE= modified carbon paste electrode, WIGE= wax-impregnated graphite electrode, BDD= boron-doped diamond, Ru= ruthenium electrode, Pt= platinum electrode, Au= gold electrode, MAu= modified gold electrode, RDE= rotating disc electrode, SDS= sodium dodecylsulfate.
VOLTAMMETRIC ANALYSIS OF ATYPICAL PSYCHOTROPIC DRUGS
| Psychotropic drug | Medium | Method | Working electrode | Range of determination [mol/l] | LOD [mol/l] | Practical application | Ref. | |
|---|---|---|---|---|---|---|---|---|
| Olanzapine | Phosphate buffer, pH=2.5 | LSV | GC | 1.97·10−5-1.59·10−4 | 9.54·10−6 | Drugs preparations | 90 | |
| Fluoxetine | Ringer buffer, pH=12 | AdSV | Hg | - | 91 | |||
| CV, | - | - | ||||||
| DPV | - | - | ||||||
| SWV | 5.2·10−5 -5.2·10−5 | 3.9·10−8 | ||||||
| Paroxetine | Borate buffer, pH=8.8 | AdSV, SWV, | Hg | 3·10−6 - 1.7·10−5 | 4.8·10−7 | Drugs preparations | 17 | |
| Trazodone | Britton's buffer, | ac-P, | Hg | - | - | Urine, plasma | 71 | |
| pH=10 | dc-P, DPV | 9.8·10−6 -7.8·10−5 | 7.69·10−7 | |||||
| 1.9·10−6 -5.8·10−5 | 2.54·10−7 | |||||||
| Sertraline | Borate buffer, | FIA | Hg | 2·10−7 -1.2·10−6 | 1.5·10−7 | Drugs preparations | 18 | |
| pH=8.2 | AdSV | |||||||
| SWV | ||||||||
| Sertraline | Borate buffer, pH=8.2 | AdSV SWV | Hg | 2.33·10−7 - 3.15·10−6 | 1.98·10−7 | Drugs preparations | 92 |